WASHINGTON — Maryland Medicaid now has a more rigorous authorization process required for prescription opioids and they are encouraging providers to consider non-opioids as a first-line treatment for chronic pain. They have also expanded reimbursement for substance abuse programs.
These new tactics to combat the opioid crisis took effect July 1st, 2017.
“The implementation of these two initiatives help us reach providers and participants by reducing the number of opioids prescribed and ensuring the vital treatment is available to those already grappling with an opioid use disorder,” Secretary Dennis R. Schrader said in a news release.
Former heroin addict turned drug abuse expert Mike Gimbel says the changes by Maryland Medicare are good ones.